TheEdgeResearch
Home / Stocks / RTEZ

Rest Ez Inc. (RTEZ)

OTC Healthcare Medical - Pharmaceuticals
$70.00 ▲ +0.00%
Market Cap
$1.93B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.25
52-Wk Range
1-70
CEO
Dylan Carson
Country
US
Currency
USD

Rest Ez Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Riverton, UT, US. The stock last traded at $70.00, up 0.00% on the session, giving a market capitalisation of $1.93B. On trailing twelve-month figures it carries a trailing P/E of 636.36, a net margin of 0.0%. Its beta of 1.25 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
636.36
Price / Sales
0.00
Price / Book
6425.30
EV / EBITDA
58411879.09
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2025-06-02
Headquarters
Riverton, UT, US
About Rest Ez Inc.

Rest Ez Inc. specializes in the production and distribution of sleep-enhancing soft gel capsules throughout the United States. The company's flagship product, also named "Rest EZ," is a soft gel dietary supplement formulated to aid sleep. These offerings are made accessible to consumers via a multi-channel sales strategy, encompassing both wholesale and retail partnerships, as well as direct purchases through its dedicated e-commerce website, www.RestEz.net. Established in 2016, Rest Ez Inc. operates from its headquarters located in Riverton, Utah.

Comparable companies

Rest Ez Inc. is most often compared with the following Healthcare names:

EBOSYEKTAFEKTAYHTSUYONTTFOSSFFRHCGFSAEYYSHPPFVTRLY
More research on RTEZ
RTEZ technical analysis RTEZ TheEdge Score Compare against peers
Open full interactive analysis & DCF →